Drug intelligence / Profile preview

Zhengtong Aerosol

Development stage: Unknown
Lead developer: Yunnan Baiyao
Administration: Topical

Overview

Zhengtong Aerosol is a topical Traditional Chinese Medicine (TCM) formulation evaluated for its analgesic and anti-inflammatory properties. It is primarily developed or studied by The First People's Hospital of Yunnan Province for the treatment of musculoskeletal conditions, specifically periarthritis of the shoulder (frozen shoulder). The aerosol is designed to provide early pain relief, reduce localized swelling, and improve joint function and range of motion. As a topical spray, it likely contains a combination of herbal extracts common to the Yunnan regional pharmacopeia, such as *Panax notoginseng*, which are known to modulate inflammatory mediators and alleviate pain at the site of application.

Brand names: Zhengtong Aerosol
Other names: Zhengtong (Swelling and Pain) AerosolZhengtong Qiwuji正痛气雾剂

Beyond the preview

Go deeper on Zhengtong Aerosol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhengtong Aerosol.

Explore the full profile